Janus Henderson Group plc 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:55 am Purchase |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
4,339,254 13.100% |
576,059 (+15.31%) |
Filing |
| 2024-11-14 12:32 pm Purchase |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
3,763,195 11.400% |
369,908 (+10.90%) |
Filing |
| 2024-08-05 12:54 pm Purchase |
2024-07-25 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
3,393,287 10.300% |
1,062,549 (+45.59%) |
Filing |
| 2024-02-14 1:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
JANUS HENDERSON GROUP PLC JHG |
2,330,738 8.700% |
2,330,738 (New Position) |
Filing |